Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fondazione Italiana Sclerosi Multipla (FISM) is the research arm of the Italian Multiple Sclerosis Association (AISM), serving as a leading non-profit organization dedicated to funding and conducting scientific research into multiple sclerosis (MS). Established in 1998, FISM coordinates and finances a wide array of research projects, ranging from basic science to clinical trials, with a focus on finding the cause of MS and improving treatments. The foundation manages the Italian MS Register, a critical epidemiological tool, and has been instrumental in international collaborations such as the Progressive MS Alliance. FISM also directly supports multi-center clinical trials, including significant studies on mesenchymal stem cells and rehabilitation strategies. Its mission is to accelerate the translation of research findings into clinical practice to enhance the quality of life for individuals living with MS.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondazione Italiana Sclerosi Multipla.